A lawsuit currently being pursued by Ohio Attorney General David Yost against OptumRx, a pharmacy benefit manager (PBM), alleges that the company bilked Ohio state coffers of more than $1.3 million on generic medications. If true, taxpayers and patients should be outraged.
But this is far from the only reason to distrust PBMs. PBMs are the corporate middlemen that drive the costs of drugs up for patients in pursuit of their own profits. Seniors, in particular, who rely on these medications in greater numbers, pay a heavy price.
Read Full Article »
